Dr. Lal Path Labs Ltd
Invesco Ltd decreased its stake in Dr. Lal Path Labs Ltd from 2.28% to 1.37%, selling 1,533,350 shares. The value of the sold shares is approximately ₹260.51 crore, based on the share price of ₹1699.00.
A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.
Invesco Ltd is a global investment management firm listed in the United States (NYSE: IVZ). Its international and Asia focused funds invest in Indian equities through the foreign portfolio investor route.